Literature DB >> 15121883

A human telomerase-associated nuclease.

Rena Oulton1, Lea Harrington.   

Abstract

Ciliate and yeast telomerase possess a nucleolytic activity capable of removing DNA from the 3' end of a single-stranded oligonucleotide substrate. The nuclease activity is thought to assist in enzyme proofreading and/or processivity. Herein, we report a previously uncharacterized human telomerase-associated nuclease activity that shares several properties with ciliate and yeast telomerases. Partially purified human telomerase, either from cell extracts or recombinantly produced, demonstrated an ability to remove 3' nontelomeric nucleotides from a substrate containing 5' telomeric DNA, followed by extension of the newly exposed telomeric sequence. This cleavage/extension activity was apparent at more than one position within the telomeric DNA and was influenced by sequences 5' to the telomeric/nontelomeric boundary and by substitution with a methylphosphonate moiety at the telomeric/nontelomeric DNA boundary. Our data suggest that human telomerase is associated with an evolutionarily conserved nucleolytic activity and support a model in which telomerase-substrate interactions can occur distal from the 3' primer end.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121883      PMCID: PMC452580          DOI: 10.1091/mbc.e04-03-0178

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  40 in total

Review 1.  Switching and signaling at the telomere.

Authors:  E H Blackburn
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

2.  Different modes of de novo telomere formation by plant telomerases.

Authors:  M S Fitzgerald; E V Shakirov; E E Hood; T D McKnight; D E Shippen
Journal:  Plant J       Date:  2001-04       Impact factor: 6.417

3.  Characterization of the interaction between the nuclease and reverse transcriptase activity of the yeast telomerase complex.

Authors:  H Niu; J Xia; N F Lue
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Generation of telomeric G strand overhangs involves both G and C strand cleavage.

Authors:  Naduparambil K Jacob; Karen E Kirk; Carolyn M Price
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

Review 5.  Promoting elongation with transcript cleavage stimulatory factors.

Authors:  Rachel N Fish; Caroline M Kane
Journal:  Biochim Biophys Acta       Date:  2002-09-13

6.  Human telomerase contains two cooperating telomerase RNA molecules.

Authors:  C Wenz; B Enenkel; M Amacker; C Kelleher; K Damm; J Lingner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

7.  Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability.

Authors:  L Marusíc; M Anton; A Tidy; P Wang; B Villeponteau; S Bacchetti
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

8.  Silver staining of proteins in polyacrylamide gels.

Authors:  W Wray; T Boulikas; V P Wray; R Hancock
Journal:  Anal Biochem       Date:  1981-11-15       Impact factor: 3.365

9.  Functional reconstitution of human telomerase expressed in Saccharomyces cerevisiae.

Authors:  F Bachand; C Autexier
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

10.  The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.

Authors:  Sylvain Huard; Tara J Moriarty; Chantal Autexier
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

View more
  16 in total

1.  Similarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase.

Authors:  Huira C Kopera; John B Moldovan; Tammy A Morrish; Jose Luis Garcia-Perez; John V Moran
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-22       Impact factor: 11.205

2.  Telomerase can act as a template- and RNA-independent terminal transferase.

Authors:  Neal F Lue; Dimitry Bosoy; Tara J Moriarty; Chantal Autexier; Brian Altman; Siyang Leng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

3.  Function, replication and structure of the mammalian telomere.

Authors:  Dominique Broccoli
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

4.  The MRT-1 nuclease is required for DNA crosslink repair and telomerase activity in vivo in Caenorhabditis elegans.

Authors:  Bettina Meier; Louise J Barber; Yan Liu; Ludmila Shtessel; Simon J Boulton; Anton Gartner; Shawn Ahmed
Journal:  EMBO J       Date:  2009-09-24       Impact factor: 11.598

5.  The Saccharomyces cerevisiae Hrq1 and Pif1 DNA helicases synergistically modulate telomerase activity in vitro.

Authors:  David G Nickens; Cody M Rogers; Matthew L Bochman
Journal:  J Biol Chem       Date:  2018-08-01       Impact factor: 5.157

6.  Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer.

Authors:  Chandan Rana; Honit Piplani; Vivek Vaish; Bimla Nehru; S N Sanyal
Journal:  Tumour Biol       Date:  2015-03-06

7.  Structural features of mouse telomerase RNA are responsible for the lower activity of mouse telomerase versus human telomerase.

Authors:  Scott J Garforth; Yan Yun Wu; Vinayaka R Prasad
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

8.  Regulation of 5' template usage and incorporation of noncognate nucleotides by human telomerase.

Authors:  Tara J Moriarty; Delphine T Marie-Egyptienne; Chantal Autexier
Journal:  RNA       Date:  2005-09       Impact factor: 4.942

9.  An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization.

Authors:  Tara J Moriarty; Ryan J Ward; Michael A S Taboski; Chantal Autexier
Journal:  Mol Biol Cell       Date:  2005-04-27       Impact factor: 4.138

10.  Biochemical properties of Trypanosoma cruzi telomerase.

Authors:  Denise P Muñoz; Kathleen Collins
Journal:  Nucleic Acids Res       Date:  2004-09-30       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.